1-tert-Butyl 2-ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate, 97%, 1g

3-BROMO-2-CHLOROPHENYLACETIC ACID, 95.0%, 5g

3'-Fluoropropiophenone, 97.00%, 100g

TERT-BUTYL N-(3-[(TERT-BUTYLDIMETHYLSILYL)OXY]-2-OXOPROPYL)CARBAMATE, 95.0%, 100mg

Benzylboronic acid pinacol ester, 97.00%, 5g

Pyridine-3,4,5-triamine, 95.0%, 250mg

Lente con corrección al infinito Plan PLi S100x/1.25 IOS

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 60, 250 ml, 160 mm, 1 pieza

2-Ethoxy-4-(4-methyl-1,3-dioxolan-2-yl)phenol, 95.0%, 100g

3-(5-Amino-1H-pyrazol-3-yl)benzonitrile, 97%, 5g

Methyl 3-bromo-5-cyanobenzoate, 95.0%, 5g

N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine, 99.0%, 10mg

6-Bromo-8-ethyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, 98%, 50mg